EXC.NASDAQExelon CORP

Form 4: Exelon Corp Director Matthew C Rogers Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Director Matthew C Rogers reports acquiring 933 common stock deferred stock units of Exelon Corp at $44.19 per unit on March 31, 2025.

Summary

  • Matthew C Rogers, a director of Exelon Corp, filed a Form 4 on April 01, 2025, reporting a transaction.
  • On March 31, 2025, Rogers acquired 933 common stock deferred stock units at a price of $44.19 per unit.
  • Following the transaction, Rogers beneficially owns 8,473 deferred stock units through the Exelon Corp Directors Deferred Stock Unit Plan.
  • The balance includes 68 additional shares acquired through automatic dividend reinvestment.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting a transaction. The acquisition of shares by a director can be seen as a mildly positive signal.

Positives

  • The acquisition of deferred stock units indicates a continued investment and alignment of interests between the director and the company's performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

  • The transaction provides shareholders with insight into the actions of company leadership.

Key Dates

DateDescription
03/31/2025Date of transaction: Acquisition of 933 common stock deferred stock units.
04/01/2025Date of Form 4 filing.

Keywords

Form 4, Exelon Corp, Director, Matthew C Rogers, Deferred Stock Units, Beneficial Ownership, Acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.